You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 24, 2024

CLINICAL TRIALS PROFILE FOR TOVIAZ


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for Toviaz

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00605319 ↗ An Open Label Study to Measure Efficacy of Fesoterodine (Toviaz) Post Surgery for Benign Prostatic Hyperplasia Completed Pfizer Phase 4 2010-01-01 The subjects who have symptoms of overactive bladder (many trips to the bathroom, and urgency with or without the inability to hold your urine until you get to the toilet) are invited to participate in this research study.
NCT00605319 ↗ An Open Label Study to Measure Efficacy of Fesoterodine (Toviaz) Post Surgery for Benign Prostatic Hyperplasia Completed Weill Medical College of Cornell University Phase 4 2010-01-01 The subjects who have symptoms of overactive bladder (many trips to the bathroom, and urgency with or without the inability to hold your urine until you get to the toilet) are invited to participate in this research study.
NCT00691093 ↗ Study In Patients With Overactive Bladder Treated With Toviaz® After Failure Of Previous Therapy Completed Pfizer 2008-07-01 This is a observational study in patients treated with fesoterodine (Toviaz), who have failed on previous treatment for overactive bladder. It will collect epidemiological data and investigate the efficacy and tolerability of fesoterodine.
NCT00713921 ↗ Neuropathic Investigation and Anticholinergic Treatment of Bladder Dysfunction in Diabetes and Stroke Patients Withdrawn Pfizer Early Phase 1 2009-09-15 Develop and quantify methods for evaluating bladder dysfunction in diabetes and stroke
NCT00713921 ↗ Neuropathic Investigation and Anticholinergic Treatment of Bladder Dysfunction in Diabetes and Stroke Patients Withdrawn Saint Thomas Health Early Phase 1 2009-09-15 Develop and quantify methods for evaluating bladder dysfunction in diabetes and stroke
NCT00713921 ↗ Neuropathic Investigation and Anticholinergic Treatment of Bladder Dysfunction in Diabetes and Stroke Patients Withdrawn Saint Thomas Health Services Early Phase 1 2009-09-15 Develop and quantify methods for evaluating bladder dysfunction in diabetes and stroke
NCT00798434 ↗ A Study to Compare the Effectiveness and Safety of Fesoterodine and Placebo in an Elderly Population of Patients Who go to the Toilet Very Frequently Due to Overactive Bladder. Completed Pfizer Phase 4 2008-06-01 The drug being studied, fesoterodine fumarate helps prevent the bladder neck opening at unwanted times and has been shown to help patients with overactive bladder syndrome pass urine less frequently than before treatment. It is postulated that this drug will also prove effective in elderly patients (aged > 65 years) and that the ability to change dose between 4 and 8mg will allow each patient to have an optimised treatment.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Toviaz

Condition Name

Condition Name for Toviaz
Intervention Trials
Overactive Bladder 10
Urinary Bladder, Overactive 5
Urinary Incontinence 2
Treatment of Overactive Bladder 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Toviaz
Intervention Trials
Urinary Bladder, Overactive 20
Urinary Incontinence 4
Enuresis 4
Urinary Incontinence, Stress 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Toviaz

Trials by Country

Trials by Country for Toviaz
Location Trials
United States 75
Canada 12
Korea, Republic of 6
United Kingdom 5
Spain 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Toviaz
Location Trials
Pennsylvania 3
Missouri 3
Florida 3
Arizona 3
Connecticut 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Toviaz

Clinical Trial Phase

Clinical Trial Phase for Toviaz
Clinical Trial Phase Trials
Phase 4 7
Phase 3 3
Phase 2 3
[disabled in preview] 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Toviaz
Clinical Trial Phase Trials
Completed 20
Terminated 2
Unknown status 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Toviaz

Sponsor Name

Sponsor Name for Toviaz
Sponsor Trials
Pfizer 19
Stéphane Bolduc 2
Saint Thomas Health 1
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Toviaz
Sponsor Trials
Industry 20
Other 17
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.